Conversations on Immunotherapy with Kerry Reynolds, MD

In this episode, host Shikha Jain, MD, speaks with Kerry Reynolds, MD, about immunotherapy-related adverse events, creating educational resources on immunotherapy management and more.

Welcome to another exciting episode of Oncology Overdrive :58
About Reynolds 1:06
The interview 2:45
Tell me about how your journey led you to this field of immunotherapy-related adverse events? 3:12
Jain and Reynolds on how immunotherapy has changed how we talk about cancer care. 5:41
How did you start the Severe Immunotherapy Complications Service? 6:16
When you envision this program, what do you feel are the short-term and long-term goals? 10:47
Can you tell me more about how you care for and manage in-patients through your program? 14:34
As we learn more, do you think there will ever be a day where all immunotherapy side effects will be able to be managed in the outpatient setting? 16:34
How do people get into this clinic, and what types of patients are admitted? 18:35
Tell me about your book, Facing Immunotherapy: A Guide for Patients and Their Families. Who is the best audience for this book? 21:35
Along with this book, are there other educational resources or initiatives that raise awareness for management of severe immunotherapy complications? 24:56
Have you encountered any challenges or obstacles while creating and maintaining educational resources and research initiatives? 27:11
Jain and Reynolds on the progress made in this space and the road ahead. 29:43
If someone could only listen to the last two minutes of this episode, what would you want them to take away? 31:10
How to contact Reynolds 32:40
Thanks for listening 33:27

Kerry Reynolds, MD, is an oncologist at the Massachusetts General Hospital Cancer Center and Assistant Professor of Medicine at Harvard Medical School.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Reynolds can be reached at MGH SIC, or via email kreynolds7@partners.org.

Published by:

Sources/Disclosures

Collapse

Disclosures: Jain reports no relevant financial disclosures. Reynolds reports BMS Institutional research support and is on the advisory board for SAGA Diagnostics.

Read more

Conversations on Immunotherapy with Kerry Reynolds, MD

Oncology Overdrive

Related Content